Literature DB >> 6130068

Pharmacology and neurochemistry of buspirone.

L A Riblet, D P Taylor, M S Eison, H C Stanton.   

Abstract

Biochemically, buspirone is unlike the benzodiazepines in that it neither stimulates nor inhibits 3H-benzodiazepine binding, does not affect the influence of GABA or halide anion on 3H-benzodiazepine binding, and does not interfere with GABA binding or uptake. Buspirone lacks anticonvulsant activity, interacts minimally with CNS depressants, and does not cause muscle relaxation. Its tranquilizing activity is characterized by the ability to (1) tame aggressive rhesus monkeys, (2) block conditioned avoidance responding in the rat, (3) inhibit shock-induced fighting in the mouse, and (4) attenuate shock-induced suppression of drinking in the rat. In vitro binding experiments indicate that buspirone lacks significant activity at several binding sites. It appears to interact only with the dopaminergic system and possesses properties that are similar to both dopamine agonists and dopamine antagonists.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6130068

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  39 in total

1.  Postviral fatigue syndrome.

Authors:  J S Bevan
Journal:  BMJ       Date:  1992-06-13

Review 2.  5-HT1A partial agonists. What is their future?

Authors:  D A Glitz; R Pohl
Journal:  Drugs       Date:  1991-01       Impact factor: 9.546

3.  Effects of non-sedative anxiolytic drugs on responses to GABA and on diazepam-induced enhancement of these responses on mouse neurones in cell culture.

Authors:  P P De Deyn; R L Macdonald
Journal:  Br J Pharmacol       Date:  1988-09       Impact factor: 8.739

Review 4.  Mechanisms of action of atypical antipsychotic drugs: a critical analysis.

Authors:  B J Kinon; J A Lieberman
Journal:  Psychopharmacology (Berl)       Date:  1996-03       Impact factor: 4.530

Review 5.  Multidisciplinary assessment and treatment of self-injurious behavior in autism spectrum disorder and intellectual disability: integration of psychological and biological theory and approach.

Authors:  Noha F Minshawi; Sarah Hurwitz; Danielle Morriss; Christopher J McDougle
Journal:  J Autism Dev Disord       Date:  2015-06

6.  Modification of cocaine self-administration by buspirone (buspar®): potential involvement of D3 and D4 dopamine receptors.

Authors:  Jack Bergman; Rebecca A Roof; Cheryse A Furman; Jennie L Conroy; Nancy K Mello; David R Sibley; Phil Skolnick
Journal:  Int J Neuropsychopharmacol       Date:  2012-07-25       Impact factor: 5.176

7.  Effects of buspirone and ipsapirone on schedule induced polydipsia: comparison with 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) and raclopride.

Authors:  C N Ryan; J L Evenden; M Petterson
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

8.  Comparative chronic effects of buspirone or neuroleptics on rat brain dopaminergic neurotransmission.

Authors:  B A McMillen
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

9.  Minimal changes with long-term administration of anxiolytics on septal driving of hippocampal rhythmical slow activity.

Authors:  X O Zhu; N McNaughton
Journal:  Psychopharmacology (Berl)       Date:  1995-03       Impact factor: 4.530

10.  Comparison of ketanserin, buspirone and propranolol on arousal, pupil size and autonomic function in healthy volunteers.

Authors:  Vassilis Koudas; Alexandra Nikolaou; Eugenia Hourdaki; Stella G Giakoumaki; Panos Roussos; Panos Bitsios
Journal:  Psychopharmacology (Berl)       Date:  2009-03-14       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.